CD79A and Hepatic fibrosis: IgA + B cells upregulate the expression of PD-L1 and inhibit the activation and cytotoxicity of T cells by secreting IL-10, and genetic or therapeutic depletion of IgA + B cells is beneficial in alleviating liver fibrosis [92] and reducing liver carcinogenesis [93].